Site icon OncologyTube

CARMENA Study Showed Sunitnib Alone | Studies Showing Single-Agent Checkpoint Inhibitors

Saby George, MD, FACP, Roswell Park Cancer Institute, talks about CARMENA Study Showed Sunitnib Alone | Studies Showing Single-Agent Checkpoint Inhibitors at Annual Meeting 2018

Exit mobile version